Leonard: ‘We believe this deal will set the platform for CCMD going into 2018 onwards’.
PHARMACEUTICAL manufacturer CCM Duopharma Biotech Bhd
’s (CCMD) chief executive officer Leonard Ariff Abdul Shatar is a man on a mission as the group prepares to embark on an ambitious consolidation plan after it acquires six pharmaceutical units from its parent company.
Leonard tells StarBizWeek that the timing is right for CCMD to take over the Chemical Company of Malaysia Bhd’s (CCM) pharmaceutical arm so it can increase its product offerings and scale via consolidating its resources.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
